A Prospective Single Institution Study of Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
Status: Withdrawn
Intervention Type: Drug
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY
Does treatment with bevacizumab (Avastin) in combination with prior or current radiotherapy lead to optic neuropathy?
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Diagnosed w Glioblastoma grade IV, and scheduled to begin chemo radiotherapy with Avastin
Time Frame
Start Date: 2011-03
Completion Date: 2012-07
Treatments
Experimental: Bevacizumab (Avastin)
Authors
Related Therapeutic Areas
Sponsors
Leads: West Penn Allegheny Health System